1903 related articles for article (PubMed ID: 8311008)
1. Adjuvant chemotherapy with dacarbazine, vindesine, and cisplatin in pathological stage II malignant melanoma.
Pectasides D; Alevizakos N; Bafaloukos D; Tzonou A; Asimakopoulos G; Varthalitis I; Dimitriadis M; Athanassiou A
Am J Clin Oncol; 1994 Feb; 17(1):55-9. PubMed ID: 8311008
[TBL] [Abstract][Full Text] [Related]
2. [Isolated hyperthermic extremity perfusion with vindesine, dacarbazine and cisplatin in the treatment of malignant melanomas].
Aigner KR; Jungbluth A; Link KH; Walther H; Müller H; Schwemmle K; Ringenberg T; Börger G; Ruppel R; Illig L
Onkologie; 1984 Dec; 7(6):348-53. PubMed ID: 6396562
[TBL] [Abstract][Full Text] [Related]
3. Dacarbazine-vindesine versus dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A randomised phase III trial.
Jungnelius U; Ringborg U; Aamdal S; Mattsson J; Stierner U; Ingvar C; Malmström P; Andersson R; Karlsson M; Willman K; Wist E; Bjelkengren G; Westberg R
Eur J Cancer; 1998 Aug; 34(9):1368-74. PubMed ID: 9849419
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant chemotherapy in malignant melanoma using dacarbazine, carmustine, cisplatin, and tamoxifen: a University of South Florida and H. Lee Moffitt Melanoma Center Study.
Saba HI; Cruse CW; Wells KE; Klein CJ; Reintgen DS
Ann Plast Surg; 1992 Jan; 28(1):60-4. PubMed ID: 1642408
[TBL] [Abstract][Full Text] [Related]
5. Treatment of metastatic malignant melanoma with dacarbazine, vindesine and cisplatin.
Pectasides D; Yianniotis H; Alevizakos N; Bafaloukos D; Barbounis V; Varthalitis J; Dimitriadis M; Athanassiou A
Br J Cancer; 1989 Oct; 60(4):627-9. PubMed ID: 2803936
[TBL] [Abstract][Full Text] [Related]
6. Dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A phase I-II trial.
Ringborg U; Jungnelius U; Hansson J; Strander H
Am J Clin Oncol; 1990 Jun; 13(3):214-7. PubMed ID: 2346126
[TBL] [Abstract][Full Text] [Related]
7. Clinical and histologic involvement of regional lymph nodes in malignant melanoma. Adjuvant vindesine improves survival.
Retsas S; Quigley M; Pectasides D; Macrae K; Henry K
Cancer; 1994 Apr; 73(8):2119-30. PubMed ID: 8156517
[TBL] [Abstract][Full Text] [Related]
8. Nine years' experience of BELD combination chemotherapy (bleomycin, vindesine, CCNU and DTIC) for metastatic melanoma.
Stables GI; Doherty VR; MacKie RM
Br J Dermatol; 1992 Nov; 127(5):505-8. PubMed ID: 1281672
[TBL] [Abstract][Full Text] [Related]
9. Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen, or vindesine plus tamoxifen: a prospective randomized study.
Cocconi G; Passalacqua R; Foladore S; Carlini P; Acito L; Maiello E; Marchi M; Gebbia V; Di Sarra S; Beretta M; Bacchi M
Melanoma Res; 2003 Feb; 13(1):73-9. PubMed ID: 12569288
[TBL] [Abstract][Full Text] [Related]
10. Combination of cisplatin, vindesine, and dacarbazine in advanced malignant melanoma. A Phase II Study of the EORTC Malignant Melanoma Cooperative Group.
Verschraegen CF; Kleeberg UR; Mulder J; Rumke P; Truchetet F; Czarnetzki B; Rozencweig M; Thomas D; Suciu S
Cancer; 1988 Sep; 62(6):1061-5. PubMed ID: 3409184
[TBL] [Abstract][Full Text] [Related]
11. The effect of tamoxifen and cisplatin on the disease-free and overall survival of patients with high risk malignant melanoma.
McClay EF; McClay ME; Monroe L; Baron PL; Cole DJ; O'Brien PH; Metcalf JS; Maize JC
Br J Cancer; 2000 Jul; 83(1):16-21. PubMed ID: 10883662
[TBL] [Abstract][Full Text] [Related]
12. Fotemustine, dacarbazine, vindesine combination chemotherapy in advanced malignant melanoma: a phase II study of 43 patients.
Rixe O; Borel C; Paraiso D; Benhammouda A; Petit T; Antoine E; Bizzari JP; Auclerc G; Soubrane C; Weil M
Melanoma Res; 1995 Dec; 5(6):419-24. PubMed ID: 8589616
[TBL] [Abstract][Full Text] [Related]
13. Dacarbazine versus dacarbazine-vindesine in disseminated malignant melanoma: a randomized phase II study.
Ringborg U; Rudenstam CM; Hansson J; Hafström L; Stenstam B; Strander H
Med Oncol Tumor Pharmacother; 1989; 6(4):285-9. PubMed ID: 2693850
[TBL] [Abstract][Full Text] [Related]
14. [Combination of dacarbazine, vindesine and interferon alpha in the treatment of metastatic melanoma].
Mansat-Krzyzanowska E; Dreno B
Ann Dermatol Venereol; 1994; 121(12):884-7. PubMed ID: 7632005
[TBL] [Abstract][Full Text] [Related]
15. [Chemotherapy of malignant melanoma].
Ishihara K
Gan To Kagaku Ryoho; 1995 Jan; 22(1):23-7. PubMed ID: 7529980
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of bleomycin, dacarbazine (DTIC) and vindesine in disseminated malignant melanoma.
Mulder NH; Sleijfer DT; de Vries EG; Schraffordt Koops H; Samson MJ; Willemse PH
J Cancer Res Clin Oncol; 1989; 115(1):93-5. PubMed ID: 2466036
[TBL] [Abstract][Full Text] [Related]
17. [Chemotherapy of malignant melanoma].
Ishihara K; Yamazaki N; Asano K
Gan To Kagaku Ryoho; 1993 Aug; 20(10):1287-92. PubMed ID: 7688498
[TBL] [Abstract][Full Text] [Related]
18. Correlation of DNA ploidy and S-phase fraction with chemotherapeutic response and survival in a randomized study of disseminated malignant melanoma.
Karlsson M; Jungnelius U; Aamdal S; Boeryd B; Carstensen J; Kågedal B; Westberg R; Wingren S
Int J Cancer; 1996 Jan; 65(1):1-5. PubMed ID: 8543385
[TBL] [Abstract][Full Text] [Related]
19. [Long-term results of adjuvant chemotherapy after therapeutic lymph node dissection in patients with cutaneous malignant melanoma].
Kretschmer L; Helmbold P; Emmert S; Marsch WC
Hautarzt; 2002 Aug; 53(8):536-41. PubMed ID: 12221468
[TBL] [Abstract][Full Text] [Related]
20. Phase I/II study of a cisplatin-taxol-dacarbazine regimen in metastatic melanoma.
Papadopoulos NE; Bedikian A; Ring S; Kim KB; Hwu WJ; Gerber DL; Homsi J; Hwu P
Am J Clin Oncol; 2009 Oct; 32(5):509-14. PubMed ID: 19506454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
